1. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study 
Dr Andrew C Hayward, MD, Ellen B Fragaszy, MSc, Alison Bermingham, PhD, Lili Wang, PhD, Andrew Copas, PhD, W John Edmunds, PhD, Neil Ferguson, DPhil, Nilu Goonetilleke, PhD, Gabrielle Harvey, MPH, Jana Kovar, PhD, Megan S C Lim, PhD, Andrew McMichael, PhD, Elizabeth R C Millett, MSc, Jonathan S Nguyen-Van-Tam, DM, Irwin Nazareth, PhD, Richard Pebody, MBChB, Faiza Tabassum, PhD, John M Watson, FRCP, Fatima B Wurie, BSc, Prof Anne M Johnson, MD, Maria Zambon, PhD 
The Lancet Respiratory Medicine 
Volume 2, Issue 6, Pages (June 2014)
DOI: /S (14)
Copyright © 2014 Hayward et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2. Figure 1
Rates of illness or PCR-confirmed influenza standardised by age and region
Rates of acute respiratory illness, influenza-like illness, and PCR-confirmed influenza per 100 000 person-weeks. Excludes illnesses known to be due to non-influenza viruses.
The Lancet Respiratory Medicine 2014 2, DOI: ( /S (14) )
Copyright © 2014 Hayward et al. Open Access article distributed under the terms of CC BY Terms and Conditions

3. Figure 2
Rates of seasonal and pandemic influenza A infection and PCR-confirmed disease
Rates of infection established through seroconversion (four-fold titre rises in unvaccinated individuals) and rates of disease established through PCR-confirmation per 100 person-seasons (95% CIs).
The Lancet Respiratory Medicine 2014 2, DOI: ( /S (14) )
Copyright © 2014 Hayward et al. Open Access article distributed under the terms of CC BY Terms and Conditions

4. Figure 3
Number of expected events in a surveillance practice serving a population of 10 000 people
Data for a typical influenza season.
The Lancet Respiratory Medicine 2014 2, DOI: ( /S (14) )
Copyright © 2014 Hayward et al. Open Access article distributed under the terms of CC BY Terms and Conditions

5. Figure 4
Immune profiles to influenza A(H1N1)pdm09 before each influenza season.
Profiles before first wave (no vaccine; A), after second wave and before third wave (B), and after third wave (C). HI=haemagglutinin inhibition.
The Lancet Respiratory Medicine 2014 2, DOI: ( /S (14) )
Copyright © 2014 Hayward et al. Open Access article distributed under the terms of CC BY Terms and Conditions